The company’s US share prices fell after jury verdicts about cow’s-milk based formulas’ potential impact on premature infants, according to a retirement fund’s complaint filed Thursday in the US District Court for the Southern District of New York.
The formula was good for bulking up low-weight infants quickly, but recent research has found strong links between cow-based products and necrotizing enterocolitis, a gastrointestinal condition in ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.